• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Australia·Financial Services·CBA.AX
Share

Commonwealth Bank of Australia Stocks

A$ 161.19Last Updated 01.07.2026

Issuer Rating

4/7
Performance

Average

Risk

Moderate

Recommendation

Hold

Market Cap

A$ 186.85B

A$ 161.19
Key Takeaways

Risk factor

Significant default risk

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

01.07.2026 19:21

Companies laid off employees because of artificial intelligence. Some came to regret it.

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Commonwealth Bank of Australia (CBA) offers an extensive array of financial services to both individual consumers and businesses across Australia, New Zealand, and other international territories. The institution is organized into several key operational segments: Retail Banking Services, Business Banking, Institutional Banking and Markets, and its New Zealand operations. Its product range includes various deposit options such as savings accounts and term deposits, general banking accounts, credit cards, and a wide selection of lending products like personal, business, and home loans, alongside financing for vehicles and equipment, and business overdrafts. CBA also facilitates international payments. Beyond core banking, it provides a comprehensive suite of insurance products, including coverage for homes and contents, motor vehicles, health, life, income protection, pets, and travel. For its corporate clientele, the bank supplies business credit cards, capital raising solutions, transaction banking services, and sophisticated risk management offerings. Commonwealth Bank of Australia was established in Sydney, Australia, in 1911, where its headquarters remain.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E. Editor's

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Slightly negative
3/7

The average target price of CBA.AX is 118 and suggests 27.7% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

01.07.2026 20:33

"A Key Source of Value and Risk": Wall Street's Top Tech Optimist Assesses SpaceX

01.07.2026 19:21

Companies laid off employees because of artificial intelligence. Some came to regret it.

01.07.2026 18:59

Meta will launch a cloud infrastructure business. It will compete with Google and Nebius

01.07.2026 18:47

BlackRock is betting on scarce resources in AI supply chains. How should you build your portfolio?

01.07.2026 18:39

Shares of pharmaceutical company Galderma plummeted: The U.S. has halted sales of a Botox generic

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026